Mycoplasma as a possible trigger for the development of idiopathic avascular necrosis of the femoral head

Abstract

BACKGROUND: The death of bone tissue cells with impaired blood supply, followed by the development of secondary arthrosis/arthritis of the adjacent joint, is most characteristic of osteonecrosis of the femoral head. This condition is common in young patients — mainly in men of working age. Hip arthroplasty at a young age has a high risk of loosening of the endoprosthesis components, which can lead to many repeated surgical interventions. In recent years, hypotheses about the possible role of infectious agents in articular pathology have been discussed, as evidenced by the detection of specific antibodies and antigens of pathogens in the joint fluid and periarticular tissues. Mycoplasmas can trigger the development of osteonecrosis because the bone marrow is the main depot and source of endogenous reinfection (when immunity is weakened).

АIM: This study aimed to identify signs of the presence of mycoplasmas in the soft tissues of the hip joint and bone marrow of the femur during hip arthroplasty in patients with idiopathic avascular necrosis of the femoral head.

MATERIALS AND METHODS: Clinical and laboratory data of 36 patients with idiopathic aseptic necrosis of the femoral head who underwent total hip arthroplasty were analyzed, and 11.1% of the patients had a history of sexually transmitted diseases. The tissues of the synovium and bone marrow were examined by polymerase chain reaction for the presence of DNA to sexually transmitted infections.

RESULTS: The average age of the patients was 42.7 years, and the average period from disease onset to the time of surgery was 46.2 months. Bilateral joint damage was found in 78% of cases, and 91.7% of the patients had stage 4 femoral head disease (ARCO). The preoperative Harris score was 33.7 points on average. In history, 4 (11.1%) patients had sexually transmitted diseases. During the study, when analyzing tissue samples of the synovial membrane and bone marrow, DNA fragments of Chlamydia trachomatis, Mycoplasma genitalium, Ureaplasma spp., and M. hominis were not isolated in any case, including in patients with previous mycoplasma and chlamydial infection.

CONCLUSION: The absence of mycoplasma suggests that a history of sexually transmitted diseases does not significantly affect the outcomes of hip arthroplasty in aseptic necrosis of the femoral head.

Keywords

mycoplasma / chlamydia / osteonecrosis / aseptic necrosis of the femoral head / joint arthroplasty / periprosthetic infection / sexually transmitted infections

References

[1] Tikhilov RM, Shubnyakov II, Kovalenko AN, et al. Rukovodstvo po khirurgii tazobedrennogo sustava. St. Petersburg: RNIITO im. R.R. Vredena; 2014. Vol. 1. P. 155–171. (In Russ).

[2] Тихилов Р.М., Шубняков И.И., Коваленко А.Н., и др. Руководство по хирургии тазобедренного сустава. Санкт-Петербург: РНИИТО им. Р.Р. Вредена, 2014. Т. 1. С. 155–171.

[3] Ilyinykh EV, Barskova VG, Lidov PI, Nasonov EL. Osteonecrosis. Part 1. Risk factors and pathogenesis. Modern Rheumatology Journal. 2013;7(1):17–24. (In Russ). doi: 10.14412/1996-7012-2013-2362

[4] Ильиных Е.В., Барскова В.Г., Лидов П.И., Насонов Е.Л. Остеонекроз. Часть 1. Факторы риска и патогенез // Современная ревматология. 2013. T. 7, № 1. C. 17–24. doi: 10.14412/1996-7012-2013-2362

[5] Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med. 1992;326 (22):1473–1479. doi: 10.1056/NEJM199205283262206

[6] Mankin H.J. Nontraumatic necrosis of bone (osteonecrosis) // N Engl J Med. 1992. Vol. 326, N 22. P. 1473–1479. doi: 10.1056/NEJM199205283262206

[7] Lieberman JR, Вerry DJ, Mont MA, et al. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect. 2003;52:337–355.

[8] Lieberman J.R., Вerry D.J., Mont M.A., et al. Osteonecrosis of the hip: management in the 21st century // Instr Course Lect. 2003. Vol. 52. P. 337–355.

[9] Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77(3):459–474. doi: 10.2106/00004623-199503000-00018

[10] Mont M.A., Hungerford D.S. Non-traumatic avascular necrosis of the femoral head // J Bone Joint Surg Am. 1995. Vol. 77, N 3. P. 459–474. doi: 10.2106/00004623-199503000-00018

[11] Cooper C, Steinbuch M, Stevenson R, et al. The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK. Osteoporos Int. 2010;21(4):569–577. doi: 10.1007/s00198-009-1003-1

[12] Cooper C., Steinbuch M., Stevenson R., et al. The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK // Osteoporos Int. 2010. Vol. 21, N 4. P. 569–577. doi: 10.1007/s00198-009-1003-1

[13] Ikeuchi K, Hasegawa Y, Seki T, et al. Epidemiology of nontraumatic osteonecrosis of the femoral head in Japan. Mod Rheumatol. 2015;25(2):278–281. doi: 10.3109/14397595.2014.932038

[14] Ikeuchi K., Hasegawa Y., Seki T., et al. Epidemiology of nontraumatic osteonecrosis of the femoral head in Japan // Mod Rheumatol. 2015. Vol. 25, N 2. P. 278–281. doi: 10.3109/14397595.2014.932038

[15] Zorya VI. Vozmozhnye prichiny asepticheskogo nekroza golovki bedrennoi kosti u vzroslykh i voprosy ego diagnostiki. Travmatologiya i ortopediya Rossii. 1994;(5):46–53. (In Russ).

[16] Зоря В.И. Возможные причины асептического некроза головки бедренной кости у взрослых и вопросы его диагностики // Травматология и ортопедия России. 1994. № 5. C. 46–53.

[17] Torgashin AN, Rodionova SS. Obosnovanie ispol’zovaniya antirezorbtivnykh preparatov v lechenii asepticheskogo nekroza kostei. Opinion Leader. 2020;(6):64–68. (In Russ).

[18] Торгашин А.Н., Родионова С.С. Обоснование использования антирезорбтивных препаратов в лечении асептического некроза костей // Opinion Leader. 2020. № 6. C. 64–68.

[19] Bauer TW, Geesink RC, Zimmerman R, McMahon JT. Hydroxyapatite-coated femoral stems. Histological analysis of components retrieved at autopsy. J Bone Joint Surg Am. 1991;73(10):1439–1452.

[20] Bauer T.W., Geesink R.C., Zimmerman R., McMahon J.T. Hydroxyapatite-coated femoral stems. Histological analysis of components retrieved at autopsy // J Bone Joint Surg Am. 1991. Vol. 73, N 10. P. 1439–1452.

[21] Howie DW, Haynes DR, Rogers SD, et al. The response to particulate debris. Orthop Clin North Am. 1993;24(4):571–581.

[22] Howie D.W., Haynes D.R., Rogers S.D., et al. The response to particulate debris // Orthop Clin North Am. 1993. Vol. 24, N 4. P. 571–581.

[23] Kavanagh BF, Wallrichs S, Dewitz M, et al. Charnley low-friction arthroplasty of the hip. Twenty-year results with cement. J Arthroplasty. 1994;9(3):229–234. doi: 10.1016/0883-5403(94)90076-0

[24] Kavanagh B.F., Wallrichs S., Dewitz M., et al. Charnley low-friction arthroplasty of the hip. Twenty-year results with cement // J Arthroplasty. 1994. Vol. 9, N 3. P. 229–234. doi: 10.1016/0883-5403(94)90076-0

[25] Malizos KN, Karantanas AH, Varitimidis SE, et al. Osteonecrosis of the femoral head: etiology, imaging and treatment. Eur J Radiol. 2007;63(1):16–28. doi: 10.1016/j.ejrad.2007.03.019

[26] Malizos K.N., Karantanas A.H., Varitimidis S.E., et al. Osteonecrosis of the femoral head: etiology, imaging and treatment // Eur J Radiol. 2007. Vol. 63, N 1. P. 16–28. doi: 10.1016/j.ejrad.2007.03.019

[27] Vosmaer A, Pereira RR, Koenderman JS, et al. Coagulation abnormalities in Legg-Calvé-Perthes disease. J Bone Joint Surg Am. 2010;92(1):121–128. doi: 10.2106/JBJS.I.00157

[28] Vosmaer A., Pereira R.R., Koenderman J.S., et al. Coagulation abnormalities in Legg-Calvé-Perthes disease // J Bone Joint Surg Am. 2010. Vol. 92, N 1. P. 121–128. doi: 10.2106/JBJS.I.00157

[29] Wu L, Gao C, Wang G, et al. Blood coagulation function in the patients with avascular necrosis of the femoral head (ANFH) after severe acute respiratory syndrome (SARS). Chinese Journal of Nautical Medicine and Hyperbaric Medicine. 2006;13(1):39–41.

[30] Wu L., Gao C., Wang G., et al. Blood coagulation function in the patients with avascular necrosis of the femoral head (ANFH) after severe acute respiratory syndrome (SARS) // Chinese Journal of Nautical Medicine and Hyperbaric Medicine. 2006. Vol. 13, N 1. P. 39–41.

[31] Scapinelli R. Studies on the vasculature of the human knee joint. Acta Anat (Basel). 1968;70(3):305–309. doi: 10.1159/000143133

[32] Scapinelli R. Studies on the vasculature of the human knee joint // Acta Anat (Basel). 1968. Vol. 70, N 3. P. 305–309. doi: 10.1159/000143133

[33] Yamamoto T, Bullough PG. Spontaneous osteonecrosis of the knee: the result of subchondral insufficiency fracture. J Bone Joint Surg Am. 2000;82(6):858–866. doi: 10.2106/00004623-200006000-00013

[34] Yamamoto T., Bullough P.G. Spontaneous osteonecrosis of the knee: the result of subchondral insufficiency fracture // J Bone Joint Surg Am. 2000. Vol. 82, N 6. P. 858–866. doi: 10.2106/00004623-200006000-00013

[35] Varoga D, Drescher W, Pufe M, et al. Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head. Clin Orthop Relat Res. 2009;467(12):3273–3282. doi: 10.1007/s11999-009-1076-3

[36] Varoga D., Drescher W., Pufe M., et al. Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head // Clin Orthop Relat Res. 2009. Vol. 467, N 12. P. 3273–3282. doi: 10.1007/s11999-009-1076-3

[37] Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am. 2006;88(5):1117–1132. doi: 10.2106/JBJS.E.01041

[38] Mont M.A., Jones L.C., Hungerford D.S. Nontraumatic osteonecrosis of the femoral head: ten years later // J Bone Joint Surg Am. 2006. Vol. 88, N 5. P. 1117–1132. doi: 10.2106/JBJS.E.01041

[39] Eysmont OL, Pashkevich LA, Mohammadi MT, et al. Clinical and morphological characteristics and microbiological analyzes of the hip joint tissues in patients with avascular necrosis of the femoral head. Meditsinskie novosti. 2015;(12):59–64. (In Russ).

[40] Эйсмонт О.Л., Пашкевич Л.А., Мохаммади М.Т., и др. Клинико-морфологическая характеристика и микробиологический анализ тканей тазобедренного сустава у пациентов с аваскулярным некрозом головки бедра // Медицинские новости. 2015. № 12. С. 59–64.

[41] Nikolaev NS, Pchelova NN, Preobrazhenskaya EV, et al. «Unexpected» infectionsin revision arthroplasty for aseptic loosening. Traumatology and Orthopedics of Russia. 2021;27(3):56–70. (In Russ). doi: 10.21823/2311-2905-2021-27-3-56-70

[42] Николаев Н.С., Пчелова Н.Н., Преображенская Е.В., и др. «Неожиданные» инфекции при асептических ревизиях // Травматология и ортопедия России. 2021. Т. 27, № 3. С. 56–70. doi: 10.21823/2311-2905-2021-27-3-56-70

[43] Lewington MR, El-Hawary R. Legg-Calvé-Perthes disease in a patient with albright hereditary osteodystrophy. A сase report. J Bone Joint Surg Am. 2010;92(2):450–455. doi: 10.2106/JBJS.I.00153

[44] Lewington M.R., El-Hawary R. Legg-Calvé-Perthes disease in a patient with albright hereditary osteodystrophy. A сase report // J Bone Joint Surg Am. 2010. Vol. 92, N 2. P. 450–455. doi: 10.2106/JBJS.I.00153

[45] Aya-ay J, Athavale S, Morgan-Bagley S, et al. Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head. J Bone Miner Res. 2007;22(1):93–100. doi: 10.1359/jbmr.060817

[46] Aya-ay J., Athavale S., Morgan-Bagley S., et al. Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head // J Bone Miner Res. 2007. Vol. 22, N 1. P. 93–100. doi: 10.1359/jbmr.060817

[47] Bowers JR, Dailiana ZH, McCarthy EF, Urhaniak JR. Drug therapy increases bone density in osteonecrosis of the femoral head in canines. J Surg Orthop Adv. 2004;13(4):210–216.

[48] Bowers J.R., Dailiana Z.H., McCarthy E.F., Urhaniak J.R. Drug therapy increases bone density in osteonecrosis of the femoral head in canines // J Surg Orthop Adv. 2004. Vol. 13, N 4. P. 210–216.

[49] Kim HK, Morgan-Bagley S, Kostenuik P. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis. J Bone Miner Res. 2006;21(12):1941–1954. doi: 10.1359/jbmr.060905

[50] Kim H.K., Morgan-Bagley S., Kostenuik P. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis // J Bone Miner Res. 2006. Vol. 21, N 12. P. 1941–1954. doi: 10.1359/jbmr.060905

[51] Steffen RT, Athanasou NA, Gill HS, Murray DW. Avascular necrosis associated with fracture of the femoral neck after hip resurfacing: histological assessment of femoral bone from retrieval specimens. J Bone Joint Surg Br. 2010;92(6):787–793. doi: 10.1302/0301-620X.92B6.23377

[52] Steffen R.T., Athanasou N.A., Gill H.S., Murray D.W. Avascular necrosis associated with fracture of the femoral neck after hip resurfacing: histological assessment of femoral bone from retrieval specimens // J Bone Joint Surg Br. 2010. Vol. 92, N 6. P. 787–793. doi: 10.1302/0301-620X.92B6.23377

[53] Smirnov AV. Rentgenologicheskaya diagnostika porazheniya tazobedrennykh sustavov pri revmaticheskikh zabolevaniyakh. Consilium medicum. 2003;5(8):442–446. (In Russ).

[54] Смирнов А.В. Рентгенологическая диагностика поражения тазобедренных суставов при ревматических заболеваниях // Consilium medicum. 2003. Т. 5, № 8. С. 442–446.

[55] Hungerford DS, Lennox DW. The importance of increased intraosseous pressure in the development of osteonecrosis of the femoral head: implications for treatment. Orthop Clin North Am. 1985;16(4):635–654.

[56] Hungerford D.S., Lennox D.W. The importance of increased intraosseous pressure in the development of osteonecrosis of the femoral head: implications for treatment // Orthop Clin North Am. 1985. Vol. 16, N 4. P. 635–654.

[57] Ezhov IYu, Ezhov YuI. Posttravmaticheskii asepticheskii nekroz golovki bedrennoi kosti. Travmatologiya i ortopediya Rossii. 1996;(1):22–25. (In Russ).

[58] Ежов И.Ю., Ежов Ю.И. Посттравматический асептический некроз головки бедренной кости // Травматология и ортопедия России. 1996. № 1. С. 22–25.

[59] Rubanik LV, Poleshchuk NN, Astashonok AN, et al. Yavlyaetsya li avaskulyarnyi nekroz golovki bedrennoi kosti vsegda asepticheskim? In: Sanitarno-epidemiologicheskaya sluzhba Respubliki Belarus: istoriya, aktual’nye problemy na sovremennom etape i perspektivy razvitiya: sbornik nauchnykh trudov Mezhdunarodnoi nauchno-prakticheskoi konferentsii «Zdorov’e i okruzhayushchaya sreda», posvyashchennoi 90-letiyu sanitarno-epidemiologicheskoi sluzhby Respubliki Belarus. Vol. 2. Minsk: BGMU; 2016. P. 293–297. (In Russ).

[60] Рубаник Л.В., Полещук Н.Н., Асташонок А.Н., и др. Является ли аваскулярный некроз головки бедренной кости всегда асептическим? В кн.: Санитарно-эпидемиологическая служба Республики Беларусь: история, актуальные проблемы на современном этапе и перспективы развития: сборник научных трудов Международной научно-практической конференции «Здоровье и окружающая среда», посвящённой 90-летию санитарно-эпидемиологической службы Республики Беларусь. T. 2. Минск: БГМУ, 2016. C. 293–297.

[61] Borchsenius SN, Chernova OA, Chernov VM. Mycoplasma interaction with the immune system of animals and human. Tsitologiya. 2001;43(3):240–243. (In Russ).

[62] Борхениус С.Н., Чернова О.А., Чернов В.М. Взаимодействие микоплазм с иммунной системой животных и человека // Цитология. 2001. Т. 43, № 3. С. 240–243.

[63] Arleyevsky IP, Chernova OA, Ganeyeva LA, et al. Mycoplasma SPP. Infections and myocardial infarction. Rossiiskii kardiologicheskii zhurnal. 2003;8(4):17–23.

[64] Арлеевский И.П., Чернова О.А., Танеева Л.А., и др. Микоплазменные инфекции и инфаркт миокарда // Российский кардиологический журнал. 2003. Т. 8, № 4. С. 17–23.

[65] Pokrovskaya EV. Atherosclerosis and immune system (workshop of the European Atherosclerosis Society). Kardiologiya. 2001;41(10):69–79. (In Russ).

[66] Покровская Е.В. Атеросклероз и иммунная система (по материалам семинара европейского сообщества атеросклероза) // Кардиология. 2001. Т. 41, № 10. С. 69–73.

[67] Xiang L, Lu B. Infection due to Mycoplasma hominis after left hip replacement: case report and literature review. BMC Infect Dis. 2019;19(1):50. doi: 10.1186/s12879-019-3686-z

[68] Xiang L., Lu B. Infection due to Mycoplasma hominis after left hip replacement: case report and literature review // BMC Infect Dis. 2019. Vol. 19, N 1. P. 50. doi: 10.1186/s12879-019-3686-z

[69] Watanabe K, Otabe K, Shimizu N, et al. High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow. Stem Cell Res Ther. 2018;9(1):80. doi: 10.1186/s13287-018-0811-7

[70] Watanabe K., Otabe K., Shimizu N., et al. High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow // Stem Cell Res Ther. 2018. Vol. 9, N 1. P. 80. doi: 10.1186/s13287-018-0811-7

RIGHTS & PERMISSIONS

Eco-Vector